VTCRC STORIES
Filter by Category:
February 14, 2024
Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
Read
Media Inquiries
The VTCRC is dedicated to helping journalists secure expert interviews, information, and media requests to support their stories. To request an interview, please contact Brett Malone, Ph.D., at crcmarketing@vtcrc.com. We can also connect you with the media offices of our tenant companies should you require experts in specific industries.